These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9546754)

  • 1. Dursban revisited: birth defects, U.S. Environmental Protection Agency, and Centers for Disease Control.
    Sherman JD
    Arch Environ Health; 1997; 52(5):332-3. PubMed ID: 9546754
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorpyrifos (Dursban) and Dow employees.
    Sherman JD
    Environ Health Perspect; 1999 Mar; 107(3):A132-4. PubMed ID: 10391732
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorpyrifos (Dursban)-associated birth defects: report of four cases.
    Sherman JD
    Arch Environ Health; 1996; 51(1):5-8. PubMed ID: 8629864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
    Tassinari MS; Sahin L; Yao LP
    Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):718-20. PubMed ID: 26223007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State birth defects surveillance programs directory.
    National Center on Birth Defects and Developmental Disabilities, CDC
    Teratology; 2002; 66 Suppl 1():S59-128. PubMed ID: 12239746
    [No Abstract]   [Full Text] [Related]  

  • 6. Population and case-control surveillance in the search for environmental causes of birth defects.
    Oakley GP
    Prog Clin Biol Res; 1985; 163B():27-32. PubMed ID: 2580315
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk assessment of environmental agents for developmental toxicity: current and emerging approaches.
    Dellarco VL; Kimmel CA
    Mutat Res; 1997 Dec; 396(1-2):205-18. PubMed ID: 9434870
    [No Abstract]   [Full Text] [Related]  

  • 8. Pesticides, policies and parents.
    CMAJ; 2000 Jul; 163(2):149, 151. PubMed ID: 10934972
    [No Abstract]   [Full Text] [Related]  

  • 9. North American antiepileptic drug pregnancy registry.
    Holmes LB; Wyszynski DF
    Epilepsia; 2004 Nov; 45(11):1465. PubMed ID: 15509251
    [No Abstract]   [Full Text] [Related]  

  • 10. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA's ToxRefDB.
    Knudsen TB; Martin MT; Kavlock RJ; Judson RS; Dix DJ; Singh AV
    Reprod Toxicol; 2009 Sep; 28(2):209-19. PubMed ID: 19446433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polluting Developing Brains - EPA Failure on Chlorpyrifos.
    Rauh VA
    N Engl J Med; 2018 Mar; 378(13):1171-1174. PubMed ID: 29590550
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: "Birth malformations and other adverse perinatal outcomes in four U.S. wheat-producing states".
    Burns CJ; Leonard RC
    Environ Health Perspect; 2003 Dec; 111(16):A869; author reply A869-70. PubMed ID: 14644676
    [No Abstract]   [Full Text] [Related]  

  • 13. U.S. environmental policy. EPA calls for more studies on health risks of climate change.
    Kintisch E
    Science; 2008 Jul; 321(5888):477. PubMed ID: 18653855
    [No Abstract]   [Full Text] [Related]  

  • 14. Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme.
    Kwok RK; Kaufmann RB; Jakariya M
    J Health Popul Nutr; 2006 Jun; 24(2):190-205. PubMed ID: 17195560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: Agent Orange and birth defects in Vietnam.
    Schecter A; Constable JD
    Int J Epidemiol; 2006 Oct; 35(5):1230-2. PubMed ID: 16914479
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter to the editor: Ventricular septal defects and the National Birth Defects Prevention Study.
    Rasmussen SA; Riehle-Colarusso T; Shapira SK; Honein MA; Reefhuis J;
    Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):66. PubMed ID: 21254361
    [No Abstract]   [Full Text] [Related]  

  • 17. Levetiracetam use and pregnancy outcome.
    ten Berg K; Samrén EB; van Oppen AC; Engelsman M; Lindhout D
    Reprod Toxicol; 2005; 20(1):175-8. PubMed ID: 15808801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of data screening to drug exposure in large risk factor studies of birth defects.
    Louik C; Werler M; Anderka M; Mitchell AA
    Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):713-7. PubMed ID: 26259777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
    Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
    BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal methadone dose during pregnancy and infant clinical outcome.
    Wouldes TA; Woodward LJ
    Neurotoxicol Teratol; 2010; 32(3):406-13. PubMed ID: 20102736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.